C Marc Richards Sells 17,438 Shares of Pediatrix Medical Group, Inc. (NYSE:MD) Stock

Pediatrix Medical Group, Inc. (NYSE:MD) CFO C Marc Richards sold 17,438 shares of Pediatrix Medical Group stock in a transaction dated Monday, August 12th. The shares were sold at an average price of $10.08, for a total value of $175,775.04. Following the completion of the transaction, the chief financial officer now owns 175,347 shares in the company, valued at approximately $1,767,497.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

C Marc Richards also recently made the following trade(s):

• On Friday, August 9th, C Marc Richards sold 32,562 shares of Pediatrix Medical Group stock. The shares were sold at an average price of $10.08, for a total transaction of $328,224.96.

Pediatrix Medical Group Stock Performance

Shares of NYSE MD traded down $0.02 during midday trading on Tuesday, reaching $10.11. The company had a trading volume of 617,009 shares, compared to its average volume of 962,491. Pediatrix Medical Group, Inc. has a 1 year low of $6.62 and a 1 year high of $15.00. The business’s 50-day simple moving average is $7.70 and its 200 day simple moving average is $8.48. The company has a current ratio of 1.61, a quick ratio of 1.72 and a debt-to-equity ratio of 0.89. The stock has a market cap of $850.76 million, a P/E ratio of -11.89, a P/E/G ratio of 1.78 and a beta of 1.56.

Pediatrix Medical Group (NYSE:MD) last released its earnings results on Tuesday, August 6th. The company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.03. Pediatrix Medical Group had a positive return on equity of 10.59% and a negative net margin of 12.58%. The firm had revenue of $504.30 million for the quarter, compared to the consensus estimate of $505.49 million. During the same period in the prior year, the firm earned $0.37 EPS. The firm’s revenue was up .7% on a year-over-year basis. On average, analysts forecast that Pediatrix Medical Group, Inc. will post 1.13 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Deutsche Bank Aktiengesellschaft raised shares of Pediatrix Medical Group from a “sell” rating to a “hold” rating and set a $8.00 target price for the company in a research report on Friday, June 7th. Truist Financial decreased their price objective on Pediatrix Medical Group from $10.00 to $8.00 and set a “hold” rating for the company in a report on Monday, July 15th. UBS Group boosted their target price on Pediatrix Medical Group from $9.00 to $10.50 and gave the stock a “neutral” rating in a research note on Friday. Finally, StockNews.com raised Pediatrix Medical Group from a “sell” rating to a “hold” rating in a research report on Wednesday, August 7th. Six research analysts have rated the stock with a hold rating, According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $8.90.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of MD. Boston Partners purchased a new position in Pediatrix Medical Group during the 4th quarter worth approximately $12,452,000. Invenomic Capital Management LP raised its holdings in shares of Pediatrix Medical Group by 93.3% during the fourth quarter. Invenomic Capital Management LP now owns 1,377,951 shares of the company’s stock worth $12,815,000 after purchasing an additional 664,955 shares during the last quarter. Clark Estates Inc. NY acquired a new position in Pediatrix Medical Group during the fourth quarter valued at $3,302,000. ClariVest Asset Management LLC purchased a new stake in Pediatrix Medical Group in the second quarter valued at $1,721,000. Finally, Vanguard Group Inc. grew its position in Pediatrix Medical Group by 1.6% during the 1st quarter. Vanguard Group Inc. now owns 10,557,572 shares of the company’s stock worth $105,892,000 after purchasing an additional 164,333 shares during the period. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.